Palleiko Benjamin L
Insider CIK 1366244 · KALV President, CFO, CBO & Sec'y, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 255,750 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 125,001 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 113,920 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 40,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 25,800 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 20,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 37,500 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 85,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 75,000 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 33,750 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 52,600 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 71,700 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 33,800 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 29,611 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 92,560 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 304,688 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer deriv | 2026-06-11 | 2026-06-11 | 47,354 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | D To issuer | 2026-06-11 | 2026-06-11 | 479,989 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-22 | 2026-05-26 | 10,926 | $26.78 | $292.6K | 479,989 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-21 | 2026-05-26 | 23,250 | — | $0 | 255,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-21 | 2026-05-26 | 23,250 | — | $0 | 490,915 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-18 | 2026-05-19 | 1,129 | $26.76 | $30.2K | 467,665 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-17 | 2026-05-19 | 2,419 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-17 | 2026-05-19 | 2,419 | — | $0 | 468,794 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-05-12 | 2026-05-13 | 3,322 | $26.71 | $88.7K | 466,375 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-05-11 | 2026-05-13 | 7,120 | — | $0 | 92,560 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-05-11 | 2026-05-13 | 7,120 | — | $0 | 469,697 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-04-17 | 2026-04-20 | 9,550 | $20.22 | $193.1K | 462,577 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-04-16 | 2026-04-20 | 20,312 | — | $0 | 304,688 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-04-16 | 2026-04-20 | 20,312 | — | $0 | 472,127 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-03-09 | 2026-03-10 | 6,693 | $16.08 | $107.6K | 451,815 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-03-06 | 2026-03-10 | 15,625 | — | $0 | 125,001 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-03-06 | 2026-03-10 | 15,625 | — | $0 | 458,508 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-23 | 2026-02-24 | 10,034 | $15.57 | $156.2K | 442,883 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-21 | 2026-02-24 | 23,250 | — | $0 | 279,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-21 | 2026-02-24 | 23,250 | — | $0 | 452,917 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-18 | 2026-02-19 | 1,038 | $15.00 | $15.6K | 429,667 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-17 | 2026-02-19 | 2,419 | — | $0 | 2,419 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-17 | 2026-02-19 | 2,419 | — | $0 | 430,705 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2026-02-12 | 2026-02-13 | 3,354 | $15.70 | $52.7K | 428,286 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2026-02-11 | 2026-02-13 | 7,120 | — | $0 | 99,680 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2026-02-11 | 2026-02-13 | 7,120 | — | $0 | 431,640 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2026-01-16 | 2026-01-21 | 325,000 | — | $0 | 325,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-12-08 | 2025-12-09 | 7,294 | $16.51 | $120.4K | 424,520 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-12-06 | 2025-12-09 | 15,625 | — | $0 | 140,626 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-12-06 | 2025-12-09 | 15,625 | — | $0 | 431,814 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-24 | 2025-11-26 | 10,940 | $13.45 | $147.1K | 416,189 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-21 | 2025-11-26 | 23,250 | — | $0 | 302,250 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-21 | 2025-11-26 | 23,250 | — | $0 | 427,129 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-18 | 2025-11-19 | 4,466 | $14.48 | $64.7K | 403,879 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-17 | 2025-11-19 | 2,419 | — | $0 | 4,838 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-17 | 2025-11-19 | 6,945 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-17 | 2025-11-19 | 9,364 | — | $0 | 408,345 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-11-12 | 2025-11-13 | 3,328 | $11.55 | $38.4K | 398,981 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-11-11 | 2025-11-13 | 7,120 | — | $0 | 106,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-11-11 | 2025-11-13 | 7,120 | — | $0 | 402,309 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-09-08 | 2025-09-09 | 7,294 | $15.84 | $115.5K | 395,189 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-09-06 | 2025-09-09 | 15,625 | — | $0 | 156,251 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-09-06 | 2025-09-09 | 15,625 | — | $0 | 402,483 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-22 | 2025-08-25 | 10,940 | $13.22 | $144.6K | 386,858 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-21 | 2025-08-25 | 23,250 | — | $0 | 325,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-21 | 2025-08-25 | 23,250 | — | $0 | 397,798 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-08-18 | 2025-08-19 | 4,409 | $13.19 | $58.2K | 374,548 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-17 | 2025-08-19 | 2,418 | — | $0 | 7,257 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-08-17 | 2025-08-19 | 6,944 | — | $0 | 6,945 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-08-17 | 2025-08-19 | 9,362 | — | $0 | 378,957 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-08-11 | 2025-08-13 | 113,920 | — | $0 | 113,920 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-08-11 | 2025-08-13 | 113,920 | — | $0 | 113,920 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-07-09 | 2025-07-10 | 32,979 | $15.69 | $517.4K | 369,595 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2025-07-08 | 2025-07-10 | 87,500 | — | $0 | 402,574 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-06-09 | 2025-06-10 | 7,169 | $14.50 | $104.0K | 315,074 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-06-06 | 2025-06-10 | 15,625 | — | $0 | 171,876 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-06-06 | 2025-06-10 | 15,625 | — | $0 | 322,243 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-05-22 | 2025-05-23 | 9,999 | $11.88 | $118.8K | 306,618 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-21 | 2025-05-23 | 23,250 | — | $0 | 348,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-05-21 | 2025-05-23 | 23,250 | — | $0 | 316,617 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-05-19 | 2025-05-20 | 3,808 | $11.84 | $45.1K | 293,367 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-17 | 2025-05-20 | 6,945 | — | $0 | 13,889 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-05-17 | 2025-05-20 | 2,419 | — | $0 | 9,675 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-05-17 | 2025-05-20 | 9,364 | — | $0 | 297,175 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-03-07 | 2025-03-10 | 6,669 | $11.97 | $79.8K | 287,811 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-03-06 | 2025-03-10 | 15,625 | — | $0 | 187,501 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-03-06 | 2025-03-10 | 15,625 | — | $0 | 294,480 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2025-02-21 | 2025-02-25 | 372,000 | — | $0 | 372,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2025-02-18 | 2025-02-19 | 5,104 | $9.82 | $50.1K | 278,855 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-02-17 | 2025-02-19 | 2,419 | — | $0 | 12,094 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2025-02-17 | 2025-02-19 | 6,944 | — | $0 | 20,834 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2025-02-17 | 2025-02-19 | 9,363 | — | $0 | 283,959 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-12-09 | 2024-12-09 | 7,627 | $9.75 | $74.4K | 274,596 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-12-06 | 2024-12-09 | 15,625 | — | $0 | 203,126 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-12-06 | 2024-12-09 | 15,625 | — | $0 | 282,223 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-11-18 | 2024-11-19 | 14,400 | $9.26 | $133.3K | 266,598 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 2,419 | — | $0 | 14,513 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 6,945 | — | $0 | 27,778 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-11-17 | 2024-11-19 | 20,834 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-11-17 | 2024-11-19 | 30,198 | — | $0 | 280,998 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-09-09 | 2024-09-10 | 7,352 | $12.19 | $89.6K | 250,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-09-06 | 2024-09-10 | 15,625 | — | $0 | 218,751 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-09-06 | 2024-09-10 | 15,625 | — | $0 | 258,152 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-08-19 | 2024-08-21 | 14,215 | $12.01 | $170.7K | 242,527 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 2,418 | — | $0 | 16,932 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 20,833 | — | $0 | 20,834 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-08-17 | 2024-08-21 | 6,944 | — | $0 | 34,723 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-08-17 | 2024-08-21 | 30,195 | — | $0 | 256,742 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-06-07 | 2024-06-10 | 7,465 | $11.53 | $86.1K | 224,547 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-06-06 | 2024-06-10 | 15,625 | — | $0 | 234,375 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-06-06 | 2024-06-10 | 15,625 | — | $0 | 232,012 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-05-20 | 2024-05-21 | 21,959 | $11.76 | $258.2K | 216,387 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 20,834 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 6,945 | — | $0 | 41,667 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 20,833 | — | $0 | 41,667 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-05-17 | 2024-05-21 | 2,419 | — | $0 | 19,350 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-05-17 | 2024-05-21 | 51,031 | — | $0 | 238,346 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-03-06 | 2024-03-08 | 250,000 | — | $0 | 250,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-20 | 2024-02-21 | 22,802 | $14.11 | $321.7K | 187,315 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 20,833 | — | $0 | 62,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 20,833 | — | $0 | 20,834 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 6,944 | — | $0 | 48,612 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2024-02-17 | 2024-02-21 | 2,419 | — | $0 | 21,769 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2024-02-17 | 2024-02-21 | 51,029 | — | $0 | 210,117 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2024-02-14 | 2024-02-16 | 40,855 | $15.01 | $613.2K | 159,088 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2024-02-11 | 2024-02-13 | 83,333 | — | $0 | 83,333 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2024-02-11 | 2024-02-13 | 87,500 | — | $0 | 199,943 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-11-20 | 2023-11-21 | 13,008 | $8.23 | $107.1K | 112,443 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 6,945 | — | $0 | 55,556 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 20,833 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-11-17 | 2023-11-21 | 2,419 | — | $0 | 24,188 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-11-17 | 2023-11-21 | 30,197 | — | $0 | 125,451 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-08-18 | 2023-08-21 | 13,067 | $10.73 | $140.2K | 95,254 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 2,418 | — | $0 | 26,607 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 6,944 | — | $0 | 62,501 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-08-17 | 2023-08-21 | 20,833 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-08-17 | 2023-08-21 | 30,195 | — | $0 | 108,321 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2023-05-18 | 2023-05-22 | 40,000 | — | $0 | 40,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-05-18 | 2023-05-19 | 4,037 | $10.14 | $40.9K | 78,126 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 2,419 | — | $0 | 29,025 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-05-17 | 2023-05-19 | 6,945 | — | $0 | 69,445 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-05-17 | 2023-05-19 | 9,364 | — | $0 | 82,163 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-05-22 | 6,944 | — | $0 | 76,390 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 6,944 | — | $0 | 0 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2023-02-17 | 2023-02-23 | 2,419 | — | $0 | 31,444 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2023-02-17 | 2023-02-23 | 4,954 | $7.66 | $37.9K | 72,799 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2023-02-17 | 2023-02-23 | 9,363 | — | $0 | 77,753 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2023-01-11 | 2023-05-19 | 83,334 | — | $0 | 83,334 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-11-18 | 2022-11-21 | 722 | $5.44 | $3.9K | 68,390 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-11-17 | 2022-11-21 | 2,419 | — | $0 | 33,863 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-11-17 | 2022-11-21 | 2,419 | — | $0 | 69,112 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2022-08-17 | 2022-08-19 | 2,418 | — | $0 | 36,282 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2022-08-17 | 2022-08-19 | 725 | $14.96 | $10.8K | 66,693 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2022-08-17 | 2022-08-19 | 2,418 | — | $0 | 67,418 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 25,800 | — | $0 | 25,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2022-05-17 | 2022-05-19 | 38,700 | — | $0 | 38,700 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-05-26 | 2021-05-28 | 75,000 | — | $0 | 75,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2021-02-23 | 2021-02-25 | 29,642 | — | $0 | 29,611 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 22,093 | $33.73 | $745.2K | 71,549 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 5,293 | $33.06 | $175.0K | 66,256 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 1,256 | $31.77 | $39.9K | 65,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2021-02-23 | 2021-02-25 | 1,000 | $35.40 | $35.4K | 93,642 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2021-02-23 | 2021-02-25 | 29,642 | $6.74 | $199.8K | 94,642 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 37,500 | — | $0 | 37,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2021-02-07 | 2021-02-08 | 20,000 | — | $0 | 20,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2021-02-07 | 2021-02-08 | 32,500 | — | $0 | 65,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2020-12-30 | 2021-01-04 | 358 | — | $0 | 59,253 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2020-12-30 | 2021-01-04 | 358 | $6.74 | $2.4K | 32,858 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2020-12-30 | 2021-01-04 | 358 | $20.04 | $7.2K | 32,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2020-12-16 | 2020-12-18 | 85,000 | — | $0 | 85,000 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2019-05-15 | 2019-05-17 | 33,750 | — | $0 | 33,750 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-04-22 | 2019-04-22 | 2,000 | — | $0 | 47,354 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-04-22 | 2019-04-22 | 2,000 | $8.39 | $16.8K | 34,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-22 | 2019-04-22 | 2,000 | $25.80 | $51.6K | 32,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise deriv | 2019-04-18 | 2019-04-22 | 1,073 | — | $0 | 59,611 | SEC↗ |
| KALV KalVista Pharmaceuticals, | S Sale | 2019-04-18 | 2019-04-22 | 1,073 | $25.51 | $27.4K | 32,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | M Exercise | 2019-04-18 | 2019-04-22 | 1,073 | $6.74 | $7.2K | 33,573 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-09-18 | 2018-09-20 | 52,600 | — | $0 | 52,600 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award | 2018-09-18 | 2018-09-20 | 32,500 | — | $0 | 32,500 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2018-06-04 | 2018-06-06 | 71,700 | — | $0 | 71,700 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2017-05-25 | 2017-05-26 | 33,800 | — | $0 | 33,800 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2016-12-29 | 2016-12-30 | 60,684 | — | $0 | 60,684 | SEC↗ |
| KALV KalVista Pharmaceuticals, | A Award deriv | 2016-11-22 | 2016-11-28 | 49,354 | — | $0 | 49,354 | SEC↗ |